Intelligent Bio Solutions Inc. (INBS) stock
Close on Nov 12, 2026Market cap $5.84MP/E –Yield –
Intelligent Bio Solutions Inc. grew revenue 36.5% to $4.50M over the twelve months to Sep 30, 2026. Free cash flow was -$12.05M. At the latest close the market valued the company at $5.84M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.84M
- P/E ratio
- –
- Price to sales
- 1.30
- Price to book
- 0.77
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $4.50M
- Net income
- -$12.11M
- EPS, diluted
- -$7.04
- Free cash flow
- -$12.05M
- Book value per share
- $2.45
- Diluted shares
- 3M
Trading
- Next earnings
- Feb 11, 2027 (estimated, before the open)
- Previous close
- $2.10
- Open
- $2.01
- Day's range
- $1.90 – $2.03
- Volume
- 38,995
- Average volume (20 days)
- 36,485
- Beta (5 years)
- 2.00
- 52-week range
- $1.35 – $24.90
- RSI (14 days)
- 61.5
- Volatility (1 year)
- 178.3%
- Relative volume
- 0.71×
- WACC
- 14.9%
Market cap history
Month-end market cap since 2020, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | INBS | S&P 500 | Difference | INBS per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +27.8% | -2.7% | +30.5 pts | ||
| 3 months | -24.0% | -1.7% | −22.3 pts | ||
| Year to date | -79.7% | +11.9% | −91.6 pts | ||
| 1 year | -75.7% | +12.0% | −87.6 pts | ||
| 3 years | -97.2% | +78.2% | −175.4 pts | -69.7% | +21.2% |
| 5 years | -100.0% | +73.2% | −173.2 pts | -79.0% | +11.6% |
Eight years at a glance
Fiscal years 2019 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Intelligent Bio Solutions filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Update
About Intelligent Bio Solutions
Surgical & Medical Instruments & Apparatus
Intelligent Bio Solutions Inc. is a medical technology company that develops and supplies rapid, non-invasive screening and testing solutions. Its primary offering is the Intelligent Fingerprinting Platform, which features a proprietary drug screening system that analyzes sweat from fingerprints. The system consists of single-use, tamper-evident cartridges and a portable reader unit designed to screen for substances such as opiates, cocaine, methamphetamine, benzodiazepines, cannabis, methadone, and buprenorphine. The company also distributes wearable drug-detection sweat patches. Its customers primarily include organizations in safety-critical sectors, such as construction, manufacturing, engineering, mining, transportation, and logistics, along with judicial bodies and rehabilitation treatment providers.
Company profile, executives and historyIntelligent Bio Solutions stock: common questions
What is Intelligent Bio Solutions's stock price?
INBS closed at $1.93 on Nov 12, 2026, down 8.10% on the day. Over the past 52 weeks it traded between $1.35 and $24.90.
What is Intelligent Bio Solutions's market cap?
Intelligent Bio Solutions was worth $5.84M at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is INBS's P/E ratio?
Intelligent Bio Solutions lost money over the twelve months to Sep 30, 2026 (diluted EPS -$7.04), so it has no meaningful P/E ratio.
How much revenue does Intelligent Bio Solutions make?
Intelligent Bio Solutions reported revenue of $4.50M for the twelve months to Sep 30, 2026, up 36.5% from a year earlier.
Does Intelligent Bio Solutions pay a dividend?
No. Intelligent Bio Solutions has not paid a cash dividend over the last twelve months.
When does Intelligent Bio Solutions report earnings next?
Intelligent Bio Solutions is expected to report Q2 FY2027 results on Feb 11, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has INBS stock performed over the past year?
Including dividends, INBS returned -75.7% over the past year, against +12.0% for the S&P 500.
How many INBS shares are sold short?
0M shares were sold short at the latest FINRA report, 2.16% of the float, or 3.1 days of average trading volume.
Who are Intelligent Bio Solutions's competitors?
Companies most similar to Intelligent Bio Solutions by business, industry and size include LUCD, FEMY, ICCM, SINT, ECIA.
See a number that looks wrong?